Sagimet Biosciences Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$4.89

-0.22 (-4.31%)

As of Mar 29, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target -38.7% upside

Low Target $2.20

Average Target $3.00

High Target $3.42

Current Price $4.89

Current
$4.89

Target
$3.00

$2.20 $3.00 avg $3.42

Scenario Analysis

Bear Case

$2.20

-55.0%

Low target

Base Case

$3.00

-38.7%

Avg target

Bull Case

$3.42

+-30.1%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$11.41

-57.1% from high

52-Week Low

$1.73

+182.7% from low

Target vs 52W High

$3.00

-73.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%